Uptake of Gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic Acid in Metastatic Adrenal Tumour from Hepatocellular Carcinoma
Overview
Overview
Journal
Br J Radiol
Publisher
Oxford University Press
Specialty
Radiology
Date
2011 Aug 19
PMID
21849360
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We present the case of a metastatic adrenal tumour from hepatocellular carcinoma (HCC) showing the uptake of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) on MRI. To our knowledge, this is the first case of metastatic HCC in which Gd-EOB-DTPA uptake was shown on MRI and this finding facilitated the accurate pre-operative diagnosis of a metastatic adrenal tumour.
References
1.
Kim S, Kim S, Lee J, Kim M, Jeon Y, Park Y
. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009; 192(6):1675-81.
DOI: 10.2214/AJR.08.1262.
View
2.
Elsayes K, Mukundan G, Narra V, Lewis Jr J, Shirkhoda A, Farooki A
. Adrenal masses: mr imaging features with pathologic correlation. Radiographics. 2004; 24 Suppl 1:S73-86.
DOI: 10.1148/rg.24si045514.
View
3.
Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K
. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009; 44(7):793-8.
DOI: 10.1007/s00535-009-0056-4.
View
4.
Reimer P, Rummeny E, Daldrup H, Hesse T, Balzer T, Tombach B
. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol. 1997; 7(2):275-80.
DOI: 10.1007/s003300050150.
View
5.
Caoili E, Korobkin M, Francis I, Cohan R, Platt J, Reed Dunnick N
. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 2002; 222(3):629-33.
DOI: 10.1148/radiol.2223010766.
View